Lymphoma in Dogs: Quality of Life Through Treatment

Canine lymphoma is highly treatable with chemotherapy, and modern protocols maintain quality of life while significantly extending survival.

Key Facts

Lymphoma is one of the most common canine cancers, accounting for 7-24% of all tumors
Multi-center CHOP chemotherapy protocol achieves complete remission in 80-90% of cases
Median survival with CHOP is 12-14 months; approximately 20-25% survive beyond 2 years
Most dogs tolerate chemotherapy well - quality of life during treatment is generally good
Prednisone alone achieves short-term remission but does not extend survival significantly
B-cell lymphoma has better prognosis than T-cell lymphoma
Signs of remission include reduced lymph node size, improved appetite, energy, and activity

Welfare Considerations

Lymphoma causes rapid deterioration without treatment - lethargy, lymph node enlargement, anorexia, and organ infiltration. The welfare transformation from treatment can be dramatic: dogs entering complete remission quickly regain normal activity and quality of life. Modern chemotherapy protocols cause minimal toxicity in most dogs - vomiting and lethargy occur in 25-30% but are usually mild and transient. The welfare calculation strongly favors treatment for medically eligible dogs whose owners can commit to the protocol.

What You Can Do

Pursue staging diagnostics promptly after lymphoma diagnosis to guide treatment planning
Discuss CHOP chemotherapy with a veterinary oncologist as the evidence-based treatment standard
Monitor for chemotherapy side effects and report concerning signs between appointments
Use quality of life tools to objectively assess treatment response and guide ongoing decisions
Plan honestly for relapse - discuss second-line options and end-of-life criteria with your oncologist